(Reporting by David Henry in New York; Editing by Alan Crosby)
March 27 (Reuters) – Shares of hip, knee and shoulder replacement maker Zimmer Biomet Holdings could rise 25 percent as the market sees signs that the company is recovering from merger indigestion, according to an article in the latest edition of Barron’s.
